114 related articles for article (PubMed ID: 8401544)
1. No C1840 to T mutation in RYR1 in malignant hyperthermia.
Hall-Curran JL; Stewart AD; Ball SP; Halsall JP; Hopkins PM; Ellis FR
Hum Mutat; 1993; 2(4):330. PubMed ID: 8401544
[No Abstract] [Full Text] [Related]
2. Comparison of the segregation of the RYR1 C184OT mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.
Hogan K
Anesthesiology; 1996 Feb; 84(2):29A-30A. PubMed ID: 8602659
[No Abstract] [Full Text] [Related]
3. Evidence for a spontaneous C1840-T mutation in the RYR1 gene after DNA fingerprinting in a malignant hyperthermia susceptible family.
Steinfath M; Seranski P; Singh S; Fiege M; Wappler F; Schulte Am Esch J; Scholz J
Naunyn Schmiedebergs Arch Pharmacol; 2002 Oct; 366(4):372-5. PubMed ID: 12237752
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia.
Quane KA; Healy JM; Keating KE; Manning BM; Couch FJ; Palmucci LM; Doriguzzi C; Fagerlund TH; Berg K; Ording H
Nat Genet; 1993 Sep; 5(1):51-5. PubMed ID: 8220423
[TBL] [Abstract][Full Text] [Related]
5. [Receptors, genetics and malignant hyperpyrexia].
Shapira Y; Gurman GM
Harefuah; 1997 Jun; 132(12):849-50. PubMed ID: 9264191
[No Abstract] [Full Text] [Related]
6. [Malignant hyperthermia as a complication of anesthesia: predisposition is hereditary].
Snoeck MM; Gielen MJ; Sengers RC; Padberg GW; Iles DE; Booij LH
Ned Tijdschr Geneeskd; 1997 Mar; 141(13):616-9. PubMed ID: 9190536
[TBL] [Abstract][Full Text] [Related]
7. Genomic organization of the porcine skeletal muscle ryanodine receptor (RYR1) gene coding region 4624 to 7929.
Leeb T; Schmölzl S; Brem G; Brenig B
Genomics; 1993 Nov; 18(2):349-54. PubMed ID: 8288238
[TBL] [Abstract][Full Text] [Related]
8. A mutation in the human ryanodine receptor gene associated with central core disease.
Zhang Y; Chen HS; Khanna VK; De Leon S; Phillips MS; Schappert K; Britt BA; Browell AK; MacLennan DH
Nat Genet; 1993 Sep; 5(1):46-50. PubMed ID: 8220422
[TBL] [Abstract][Full Text] [Related]
9. The structural organization of the human skeletal muscle ryanodine receptor (RYR1) gene.
Phillips MS; Fujii J; Khanna VK; DeLeon S; Yokobata K; de Jong PJ; MacLennan DH
Genomics; 1996 May; 34(1):24-41. PubMed ID: 8661021
[TBL] [Abstract][Full Text] [Related]
10. The role of the skeletal muscle ryanodine receptor (RYR1) gene in malignant hyperthermia and central core disease.
MacLennan DH; Phillips MS
Soc Gen Physiol Ser; 1995; 50():89-100. PubMed ID: 7676327
[No Abstract] [Full Text] [Related]
11. A cosmid and yeast artificial chromosome contig containing the complete ryanodine receptor (RYR1) gene.
Rouquier S; Giorgi D; Trask B; Bergmann A; Phillips MS; MacLennan DH; de Jong P
Genomics; 1993 Aug; 17(2):330-40. PubMed ID: 8406483
[TBL] [Abstract][Full Text] [Related]
12. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
McCarthy TV; Quane KA; Lynch PJ
Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
[TBL] [Abstract][Full Text] [Related]
13. A simple method to detect the RYR1 mutation G1021A, a cause of malignant hyperthermia susceptibility.
Alestrøm A; Fagerlund TH; Berg K
Clin Genet; 1995 May; 47(5):274-5. PubMed ID: 7554356
[TBL] [Abstract][Full Text] [Related]
14. Multipoint mapping of the central core disease locus.
Schwemmle S; Wolff K; Palmucci LM; Grimm T; Lehmann-Horn F; Hübner C; Hauser E; Iles DE; MacLennan DH; Müller CR
Genomics; 1993 Jul; 17(1):205-7. PubMed ID: 8406450
[TBL] [Abstract][Full Text] [Related]
15. [Physiology and physiopathology of ryanodine receptors in swine. Significance of sensitivity to stress, stress myopathies, malignant hyperthermia and meat quality].
Martens H
Tierarztl Prax; 1997 Jan; 25(1):41-51. PubMed ID: 9157629
[TBL] [Abstract][Full Text] [Related]
16. Detection of a novel common mutation in the ryanodine receptor gene in malignant hyperthermia: implications for diagnosis and heterogeneity studies.
Quane KA; Keating KE; Manning BM; Healy JM; Monsieurs K; Heffron JJ; Lehane M; Heytens L; Krivosic-Horber R; Adnet P
Hum Mol Genet; 1994 Mar; 3(3):471-6. PubMed ID: 8012359
[TBL] [Abstract][Full Text] [Related]
17. Ryanodine receptor gene point mutation and malignant hyperthermia susceptibility.
Moroni I; Gonano EF; Comi GP; Tegazzin V; Prelle A; Bordoni A; Bresolin N; Scarlato G
J Neurol; 1995 Feb; 242(3):127-33. PubMed ID: 7751854
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel mutation in the ryanodine receptor gene (RYR1) in patients with malignant hyperthermia.
Rueffert H; Kraus H; Olthoff D; Deutrich C; Froster UG
Hum Mutat; 2001 Mar; 17(3):238. PubMed ID: 11241852
[No Abstract] [Full Text] [Related]
19. Functional characterization of a distinct ryanodine receptor mutation in human malignant hyperthermia-susceptible muscle.
Richter M; Schleithoff L; Deufel T; Lehmann-Horn F; Herrmann-Frank A
J Biol Chem; 1997 Feb; 272(8):5256-60. PubMed ID: 9030597
[TBL] [Abstract][Full Text] [Related]
20. Search for three known mutations in the RYR1 gene in 48 Danish families with malignant hyperthermia.
Fagerlund T; Ording H; Bendixen D; Berg K
Clin Genet; 1994 Dec; 46(6):401-4. PubMed ID: 7889656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
